Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.
Press releases published on May 12, 2025
Sol Endocrinology Highlights the Critical Link Between PCOS and the Endocrine System
EIN Presswire
·
May 12, 2025
Sol Endocrinology specializes in hormone health, offering evidence-based care for PCOS and related endocrine disorders. DALLAS, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Sol Endocrinology, a leading medical practice specializing in hormone …
Adaptive Training Foundation Welcomes Class 33, Proudly Sponsored by Global Medical Response
EIN Presswire
·
May 12, 2025
$100,000 Sponsorship Brings ATF’s Transformative Redefine and ReDeploy Programs to 13 Adaptive Athletes CARROLLTON, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Adaptive Training Foundation (ATF), proudly announces the launch of Class 33 of its …
Snellings Law Honors April Nurse Giveaway Winners for Their Outstanding Service and Compassion
EIN Presswire
·
May 12, 2025
Three North Texas nurses honored for extraordinary compassion, mentorship, and lifesaving care through Snellings Law’s monthly Nurse Giveaway Program. FRISCO, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Snellings Law is proud to announce the …
Cognigy and SpinSci Technologies Announce AI-Enabled Patient Access with Real-Time EHR Integration at HIMSS Texas 2025
EIN Presswire
·
May 12, 2025
DALLAS, TEXAS, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Cognigy, a global leader in AI-powered customer service solutions, and SpinSci Technologies, a pioneer in EHR-integrated patient access solutions, today announced a strategic …
Modern Heart and Vascular Opens State-of-the-Art Facility at Texas Medical Center Featuring Advanced Diagnostic Services
EIN Presswire
·
May 12, 2025
Modern Heart and Vascular Opens State-of-the-Art Facility at Texas Medical Center Featuring Advanced Diagnostic Services HOUSTON, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Modern Heart and Vascular is excited to announce the opening of its …
Michael G. Wallace Joins GetHairMD, LLC as COO & CFO, Reuniting with Paul R. Herchman Jr.
EIN Presswire
·
May 12, 2025
Bruce Vermeulen Elevated to Co-CEO Amid Rapid National Expansion SOUTHLAKE, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- GetHairMD, LLC, a leading innovator in medically proven hair restoration solutions with exclusive protected territories for …
Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance
GlobeNewswire
·
May 12, 2025
Fort Mill, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, today announced that it has …
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
GlobeNewswire
·
May 12, 2025
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright …
Retirement Tax Consultants Reveals Strategy to Cut Taxes on Roth Conversions by Up to 35% Using LLC Discounts
EIN Presswire
·
May 12, 2025
The Best Way to Save on Roth Conversion Taxes You've Never Heard Of MCKINNEY, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Retirement Tax Consultants, a leading authority in retirement tax reduction planning, today announced a powerful strategy …
Scientific Industries to Host First Quarter Fiscal Year 2025 Financial Results Investor Call on May 14, 2025
GlobeNewswire
·
May 12, 2025
BOHEMIA, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a life sciences tool provider, and a developer of digitally simplified bioprocessing products, announced it will file a Form 10Q and issue a press release after the …
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
GlobeNewswire
·
May 12, 2025
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 12, 2025
BEDFORD, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis (“OA”) pain management and regenerative solutions spaces focused on early intervention orthopedics, today announced that on May …
Quipt Home Medical Reports Fiscal Second Quarter 2025 Results
GlobeNewswire
·
May 12, 2025
CINCINNATI, May 12, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal second quarter 2025 …
New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
GlobeNewswire
·
May 12, 2025
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide …
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
May 12, 2025
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context …
ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress
GlobeNewswire
·
May 12, 2025
KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for Cholesterol Efflux MediatorTM VAR 200 in patients with diabetic kidney disease (DKD). Obesity-associated cardiometabolic preclinical …
BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 12, 2025
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in …
Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
GlobeNewswire
·
May 12, 2025
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1 study of TNX- …
Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
GlobeNewswire
·
May 12, 2025
MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and …
Vireo Growth Inc. Announces Closing of WholesomeCo Cannabis & Arches Merger Transactions
GlobeNewswire
·
May 12, 2025
– Acquisitions strengthen profitability and competitive position with proprietary technology platform – – Missouri and Nevada transactions remain on track to close during the second quarter of 2025 – MINNEAPOLIS, May 12, 2025 (GLOBE NEWSWIRE) -- Vireo …